| Descriptor English: | Signaling Lymphocytic Activation Molecule Family | ||||||
| Descriptor Spanish: |
Familia de Moléculas Señalizadoras de la Activación Linfocitaria
| ||||||
| Descriptor Portuguese: | Família de Moléculas de Sinalização da Ativação Linfocitária | ||||||
| Descriptor French: | Famille des molécules de signalisation de l'activation des lymphocytes | ||||||
| Entry term(s): |
SLAM Family Receptors SLAMF Receptors Signaling Lymphocytic Activation Molecule Family Receptors Signaling Lymphocytic Activation Molecule Receptors Signaling Lymphocytic Activation Molecules |
||||||
| Tree number(s): |
D09.400.430.890.736 D12.776.395.550.736 D12.776.543.550.746 D12.776.543.750.705.970 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000071176 | ||||||
| Scope note: | Type-I membrane glycoproteins that are expressed primarily on the surface of CD4 or CD8-positive T-CELLS; NATURAL KILLER CELLS; and some populations of B CELLS. They are characterized by an N-terminal, extracellular IMMUNOGLOBULIN-LIKE DOMAIN and a membrane-proximal IMMUNOGLOBULIN C2-SET DOMAIN. SLAMF receptors typically signal through homophilic interactions and are important for mediating the immune response and immune cell differentiation. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CH chemistry CL classification DE drug effects DF deficiency GE genetics HI history IM immunology IP isolation & purification ME metabolism PH physiology RE radiation effects TU therapeutic use UL ultrastructure |
||||||
| Previous Indexing: |
Antigens, CD (1997-2016) Receptors, Cell Surface (1997-2016) |
||||||
| Public MeSH Note: | 2017 |
||||||
| History Note: | 2017 |
||||||
| DeCS ID: | 56632 | ||||||
| Unique ID: | D000071176 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2017/01/01 | ||||||
| Date of Entry: | 2016/07/08 | ||||||
| Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Signaling Lymphocytic Activation Molecule Family
- Preferred
| Concept UI |
M000613385 |
| Scope note | Type-I membrane glycoproteins that are expressed primarily on the surface of CD4 or CD8-positive T-CELLS; NATURAL KILLER CELLS; and some populations of B CELLS. They are characterized by an N-terminal, extracellular IMMUNOGLOBULIN-LIKE DOMAIN and a membrane-proximal IMMUNOGLOBULIN C2-SET DOMAIN. SLAMF receptors typically signal through homophilic interactions and are important for mediating the immune response and immune cell differentiation. |
| Preferred term | Signaling Lymphocytic Activation Molecule Family |
| Entry term(s) |
SLAM Family Receptors SLAMF Receptors Signaling Lymphocytic Activation Molecule Family Receptors Signaling Lymphocytic Activation Molecule Receptors Signaling Lymphocytic Activation Molecules |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
